PARP1 and cancer: In addition, it has already been shown by our group and others that PARP inhibition further sensitizes cancer cells to oxidative stress, highlighting the use of PARP inhibitors in combination with ROS-inducing compounds to induce synthetic lethality [22,25,26,27,28,29].